Clinical Trial Update: Phase Ⅰb/Ⅱ Study of HS-10506 in Chinese Participants With Insomnia Disorder [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for HS-10506 in Chinese participants with insomnia disorder spanning Phase 1b/II, status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia Disorder

Drugs mentioned

• HS-10506

Snippet

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Conditions: Insomnia Disorder | Phase 1, Phase 2 | Status: UNKNOWN